NVLX-0.22. Nuvilex Secures Worldwide License for Insulin-Producing Cells From University of Technology, Sydney, for Use in Developing Diabetes Treatment http://finance.yahoo.com/news/nuvilex-secures-worldwide-license-insulin-130000661.html